Derfor skal samtidig brug undgås, med mindre fordelen for patienten opvejer risikoen for systemiske bivirkninger forårsaget af glukokortikoider.
Information about this interaction is lacking for inhaled fluticasone propionate, but a marked increase in fluticasone propionate plasma levels is expected.